HomeMYNZ • NASDAQ
Mainz Biomed NV
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 186.61K | -13.11% |
Operating expense | 4.43M | -34.08% |
Net income | -5.31M | -2.51% |
Net profit margin | -2.85K | -17.98% |
Earnings per share | — | — |
EBITDA | -4.12M | 34.76% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.24M | -11.81% |
Total assets | 13.24M | -14.09% |
Total liabilities | 7.19M | -40.86% |
Total equity | 6.05M | — |
Shares outstanding | 3.04M | — |
Price to book | 0.80 | — |
Return on assets | -81.31% | — |
Return on capital | -115.52% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.31M | -2.51% |
Cash from operations | -4.47M | 3.92% |
Cash from investing | 110.92K | 142.37% |
Cash from financing | 7.02M | 102.67% |
Net change in cash | 2.63M | 216.87% |
Free cash flow | -2.42M | 29.83% |
Previous close
$2.10
Day range
$2.03 - $2.14
Year range
$2.03 - $40.40
Market cap
4.87M USD
Avg Volume
238.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Website
Employees
19
